Actively Recruiting
Thermovision-controlled Lumbar Sympathetic Blockade in Chronic Limb-threatening Ischemia Treatment
Led by EPC Education s.r.o. · Updated on 2023-11-01
60
Participants Needed
1
Research Sites
149 weeks
Total Duration
On this page
Sponsors
E
EPC Education s.r.o.
Lead Sponsor
S
Slovak Academy of Sciences
Collaborating Sponsor
AI-Summary
What this Trial Is About
Thermovision-controlled lumbar sympathetic blockade in chronic limb-threatening ischemia treatment
CONDITIONS
Official Title
Thermovision-controlled Lumbar Sympathetic Blockade in Chronic Limb-threatening Ischemia Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with chronic limb-threatening ischemia and chronic leg pain lasting at least 6 months with pain intensity of 5 or higher on the Visual Analog Scale
- Participants or their legal guardians who fully understand the clinical trial details and have signed the informed consent form
You will not qualify if you...
- Chronic venous insufficiency
- Women with a positive pregnancy test before the trial or planning to become pregnant within the next 3 years
- Patients deemed inappropriate for the study by the staff
- Disagreement with participation in the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Europainclinics
Košice, Slovakia, 04011
Actively Recruiting
Research Team
L
Ladislav Kočan, MD, PhD, FIPP
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here